New screen boosts accuracy of standard PSA test
HealthDay – A new blood test greatly reduces false-positive results in prostate cancer screenings and, when used in combination with a prostate-specific antigen (PSA) test, could prevent many unnecessary biopsies, U.S. researchers say.
Short URL: http://www.news.synavista.com/?p=3113
